Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and May 2026.
- Largest single sale: $478K (11,050 shares) of Axogen, Inc. on May 7, 2026. Filing
- Last sale before this period: Jun 9, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Axogen, Inc. (AXGN) | Director | Jul 21, 2021 | Jun 26, 2026 |
| Eli Lilly (LLY) | Former Sr. VP, Oncology Business Unit |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 19, 2026, Axogen, Inc.: 14,150 shares vested. 1 filing: 1
- May 7, 2026, Axogen, Inc.: sold 11,050 shares for $478K, no plan disclosed; 11,050 shares acquired by exercising options. 1 filing: 1
- Dec 9, 2025, Axogen, Inc.: sold 21,686 shares for $650K, no plan disclosed; 8,545 shares acquired by exercising options. 1 filing: 1
- Dec 8, 2025, Axogen, Inc.: sold 23,693 shares for $740K, no plan disclosed; 11,891 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.